M. Fava

发表

Sensitivity to imatinib therapy may be predicted by testing Wilms tumor gene expression and colony growth after a short in vitro incubation

M. Baccarani, D. Cilloni, F. Messa, 2004, Cancer.

Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias.

F. Lo‐Coco, D. Cilloni, F. Messa, 2003, Blood.

Molecular monitoring in patients with chronic myelogenous leukemia

D. Cilloni, G. Saglio, E. Gottardi, 2008, Current hematologic malignancy reports.

Significant C orrelation B etween t he D egree o f WT1 Expression and t he I nternational P rognostic S coring S ystem S core i n Patients W ith M yelodysplastic S yndromes

A. Levis, D. Cilloni, F. Messa, 2003 .

WT1 transcript amount discriminates secondary or reactive eosinophilia from idiopathic hypereosinophilic syndrome or chronic eosinophilic leukemia

M. Baccarani, M. Rondoni, G. Martinelli, 2007, Leukemia.

Real-time quantitative PCR (RQ-PCR) detection of minimal residual disease (MRD) by optimized WT1 assay to enhance risk stratification in acute myeloid leukemia (AML): A European leukemia net study [Abstract]

R. Hills, S. Schnittger, C. Preudhomme, 2007 .

Early prediction of treatment outcome in acute myeloid leukemia by measurement of WT1 transcript levels in peripheral blood samples collected after chemotherapy

F. Lo‐Coco, G. Martinelli, M. Sanz, 2008, Haematologica.

Real-time quantitative polymerase chain reaction detection of minimal residual disease by standardized WT1 assay to enhance risk stratification in acute myeloid leukemia: a European LeukemiaNet study.

V. V. D. van der Velden, R. Hills, S. Schnittger, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches.

G. Perrone, C. Panuzzo, G. Saglio, 2007, Cancer research.

Potential Targets for Immunotherapy Approaches Tumor-Specific Fusion Proteins that May Represent Positive Leukemias Result in Novel − Chromosome Alternative BCR / ABL Splice Variants in Philadelphia

G. Perrone, C. Panuzzo, G. Saglio, 2007 .

CMV seropositivity and mycosis fungoides—the Indian perspectives

F. Lo‐Coco, D. Cilloni, F. Messa, 2003 .

Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.

A. Levis, D. Cilloni, F. Messa, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Usefulness of the quantitative assessment of PRV-1 gene expression for the diagnosis of polycythemia vera and essential thrombocythemia patients.

D. Cilloni, F. Messa, F. Arruga, 2004, Blood.

Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection.

D. Cilloni, F. Messa, G. Saglio, 2003, Blood.

ABL Mutations in Late-Chronic Phase Chronic Myeloid Leukemia Patients with Cytogenetic Refractoriness to Imatinib Are Associated with a Greater Likelihood of Progression to Blast Crisis and Shorter Survival. on behalf of the GIMEMA Working Party on Chronic Myeloid Leukemia.

M. Baccarani, G. Rosti, G. Martinelli, 2004 .